Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4095069
Max Phase: Preclinical
Molecular Formula: C19H28N2O
Molecular Weight: 300.45
Molecule Type: Small molecule
Associated Items:
ID: ALA4095069
Max Phase: Preclinical
Molecular Formula: C19H28N2O
Molecular Weight: 300.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCNC(=O)c1cc2c(C)cc(C)cc2[nH]1
Standard InChI: InChI=1S/C19H28N2O/c1-4-5-6-7-8-9-10-20-19(22)18-13-16-15(3)11-14(2)12-17(16)21-18/h11-13,21H,4-10H2,1-3H3,(H,20,22)
Standard InChI Key: CSNNMOMGBOYUHW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 300.45 | Molecular Weight (Monoisotopic): 300.2202 | AlogP: 4.88 | #Rotatable Bonds: 8 |
Polar Surface Area: 44.89 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.20 | CX LogD: 5.20 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.67 | Np Likeness Score: -0.75 |
1. Franz ND, Belardinelli JM, Kaminski MA, Dunn LC, Calado Nogueira de Moura V, Blaha MA, Truong DD, Li W, Jackson M, North EJ.. (2017) Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity., 25 (14): [PMID:28545813] [10.1016/j.bmc.2017.05.015] |
Source(1):